Clinical Oncology Next-generation Sequencing MarketThe clinical oncology next-generation sequencing market share is expected to reach a value of US$ 449.4 million by 2022. Owing to the increasing application of next-generation sequencing (NGS) in clinical oncology for more effective, individualised cancer treatment,.
Clinical Oncology Next-generation Sequencing Market is reaching a valuation of US$ 1 14 Billion by 2029 - Comprehensive Research Report by FMI forextv.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from forextv.com Daily Mail and Mail on Sunday newspapers.